NVAX Stock Tanks as HHS Secretary Raises Concern Over COVID-19 Jab

Shares of Novavax (NVAX) were down 19.6% on April 10 after the United States Health and Human Services (“HHS”) Secretary Robert F. Kennedy Jr., a well-known vaccine skeptic, raised concerns regarding the efficacy of the company’s protein-based COVID-19 vaccine.In a recent interview with CBS News, the HHS Secretary raised concerns about NVAX’s COVID-19 vaccine. He stated that it employs a single-antigen approach and mentioned that it has never worked for such respiratory diseases. The HHS Secretary also said ...